Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Giuseppe Milone, Salvatore Leotta, Sara Frazzetto, Giulia Giuffrida, Giulio Antonio Milone, Sebastiano Fiore, Benedetta Esposito, Giordana Brunetti, Andrea Spadaro, Maria Grazia Camuglia, Alessandra Cupri

Blood (2023) 142 (Supplement 1): 7005.

https://doi.org/10.1182/blood-2023-172724

Published: 2023

Journal Articles

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

Alessandra Cupri, MD, Salvatore Leotta, MD, Uros Markovic, MD, Maria Grazia Camuglia, PhD, Giulio Antonio Milone, MD, Angelo Curto Pelle, MD, Valerio Leotta, MD, Mary Ann Di Giorgio, MD, Anna Bulla, MD, Di Marco Anna Lia, PhD, Gaetano Moschetti, MD, Giuseppe Milone, MD PhD

Blood (2019) 134 (Supplement_1): 3271.

https://doi.org/10.1182/blood-2019-127120

Published: 2019

Journal Articles

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Giuseppe Milone, MDPhD, Annalia DiMarco, Giuseppe Sapienza, Salvatore Leotta, Luca Scalise, Carla Consoli, Maria Cristina Pirosa, Alessandra Cupri, Gaetano Moschetti, Maria Grazia Camuglia, Maria Sciacca, AnnaElisa Marchese, PhD

Blood (2017) 130 (Supplement 1): 5098.

https://doi.org/10.1182/blood.V130.Suppl_1.5098.5098

Published: 2017

Journal Articles

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Giuseppe Milone, MD, Massimo Martino, Annalia Di Marco, BS, Salvatore Leotta, MD, Andrea Spadaro, MD, Mara Morelli, MD, Giuseppe Avola, Maria Grazia Camuglia, Alessandra Cupri, MD, Valentina Zammit, MD, Potito Rosario Scalzulli, MD, Calafiore Valeria, MD, Attilio Olivieri, MD, Giovanni Tripepi, PhD

Blood (2015) 126 (23): 4305.

https://doi.org/10.1182/blood.V126.23.4305.4305

Published: 2015

Journal Articles

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Giuseppe Milone, MD, Giuseppe Avola, Maria Grazia Camuglia, Salvatore Leotta, MD, Alessandra Cupri, Andrea Spadaro, MD, Giovanni Tripepi, MD

Blood (2014) 124 (21): 1160.

https://doi.org/10.1182/blood.V124.21.1160.1160

Published: 2014

Journal Articles

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Giuseppe Milone, Salvatore Leotta, Giuseppe Avola, Massimo Poidomani, Maria Grazia Camuglia and Andrea Spadaro

Blood (2010) 116 (21): 4563.

https://doi.org/10.1182/blood.V116.21.4563.4563

Published: 2010

Journal Articles

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Giuseppe Milone, MD, Benedetto Farsaci, MD, Giuseppe Avola, BD, Salvatore Mercurio, BD, Aurora Strano, BD, Maria Grazia Camuglia, BD, Valeria Pinto, MD, Antonella Privitera, BD, Salvatore Leotta, MD, Massimo Poidomani, MD, Stefania Coppoletta, MD, Elisa Mauro, MD, Pamela Murgano, MD, Katia Battiato, MD, Andrea Spataro, MD, Anna Triolo, MD, Rosario Giustolisi, MD

Blood (2007) 110 (11): 2849.

https://doi.org/10.1182/blood.V110.11.2849.2849

Published: 2007

NARROW

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Email alerts

ASH Publications

American Society of Hematology

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only